Patent · US Active

Immunogenic composition

US9789179B2 · kind B2 · utility

10Cited by

18References

39Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Ralph Leon Biemans · Rixensart, BE
Dominique Boutriau · Rixensart, BE
Carine Capiau · Rixensart, BE
Philippe Denoel · Rixensart, BE
Pierre Duvivier · Rixensart, BE
Jan Poolman · Broek in Waterland, NL

Key dates

Filing date	Jun 23, 2006
Grant date	Oct 17, 2017
Priority date	—
Expiry date	Dec 2, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application discloses an immunogenic composition comprising N. meningitidis capsular polysaccharides from at least one of serogroups A, C, W135 and Y conjugated to a carrier protein to produce a N. meningitidis capsular polysaccharide conjugate, wherein the average size of each N. meningitidis polysaccharide is above 50 kDa.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.